Intrauterine administration of autologous hCG- activated peripheral blood mononuclear cells improves pregnancy outcomes in patients with recurrent implantation failure; A double-blind, randomized control trial study
Journal of Reproductive Immunology2020Vol. 142, pp. 103182–103182
Citations Over TimeTop 10% of 2020 papers
Zahra Pourmoghadam, Mohammad Sadegh Soltani‐Zangbar, Golshan Sheikhansari, Ramyar Azizi, Shadi Eghbal‐Fard, Hamed Mohammadi, Homayoon Siahmansouri, Leili Aghebati‐Maleki, Shahla Danaii, Amir Mehdizadeh, Mohammad Hojjat‐Farsangi, Roza Motavalli, Mehdi Yousefi
Related Papers
- → Recurrent miscarriage: a defect in nature's quality control?(2002)176 cited
- → Maternal KIR haplotype influences live birth rate after double embryo transfer in IVF cycles in patients with recurrent miscarriages and implantation failure(2014)80 cited
- → The effectiveness of IVIG therapy in pregnancy and live birth rate of women with recurrent implantation failure (RIF): A systematic review and meta-analysis(2019)44 cited
- → Preimplantation Genetic Screening: An Effective Testing for Infertile and Repeated Miscarriage Patients?(2010)9 cited